Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

Leadership skills must adapt for rare disease success

In pharmaphorum’s rare disease focus month, Karl Simpson of Liftstream explores whether a different set of skills, experience and talent are required to develop orphan drugs, and questions how different the business model of rare diseases is. The article was … Continue reading

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , | Leave a comment

Hans Schikan new Chair at InteRNA and Asceneuron

Hans Schikan is former Chief Executive Officer of Prosensa, a biopharmaceutical company focusing on novel RNA modulating treatments for rare diseases like Duchenne muscular dystrophy. Prosensa was listed on NASDAQ (RNA) since June 2013. The company was acquired by BioMarin … Continue reading

Posted in Board Director Appointments | Tagged , , , , , , , | Leave a comment

Rare Disease biotech Aldeyra raises $25m in IPO

Authored by James Sheppard The Boston biotech cluster based company Aldeyra Therapeutics have raised $25m in an oversubscribed initial public offering (IPO). Aldeyra Therapeutics are developing treatments for rare skin and eye diseases. The clinical stage biotech company’s lead candidate … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , | Leave a comment

EURORDIS recognises Orphan Europe and Swedish Orphan Biovitrum (SOBI) with awards

Authored by Karl Simpson EURORDIS (European Organisation for Rare Diseases) has handed two prestigious accolades to two European companies at the very heart of rare diseases drug development. Orphan Europe, based in Paris and part of the Recordati Group, was … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , | Leave a comment

New Enterprise Associates backs veteran rare diseases executive team

Authored by Karl Simpson New Enterprise Associates (NEA) has been showing its increasing appetite for rare disease investments as it puts it recent fund to work. With money already invested in companies like Cydan Corporation (led by Cristina Csimma), KLS … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , | Leave a comment

Dr Francois Nader – NPS Pharmaceuticals – Executive Leadership Series

Authored by Karl Simpson At the beginning of 2013 Liftstream profiled 13 life science leaders we believed were going to make an impact over the course of the year. Below we outline how Dr Francois Nader performed for NPS Pharmaceuticals in 2013. 2013 Liftstream … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , | Leave a comment

Mr David Mott – NEA – Executive Leadership Series

Authored by Karl Simpson At the beginning of 2013 Liftstream profiled 13 life science leaders we believed were going to make an impact over the course of the year. Below we outline how Mr David Mott performed for NEA in 2013. 2013 Liftstream Analysis: NEA scored … Continue reading

Posted in Pharmaceutical business | Tagged , , , , , , , , , | Leave a comment

Jazz Pharmaceuticals to acquire rare disease company Gentium

Authored by James Sheppard Jazz Pharmaceuticals, based in Dublin, Ireland, recently announced that it had acquired Italian based rare disease drug company Gentium in a $1bn deal. The deal will give Jazz access to Gentium’s 3 marketed products and extensive … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , | 2 Comments

5 trends for Drug Regulatory Affairs recruitment in 2014!

Authored by Karl Simpson Since Liftstream was founded 10 years ago this year, the company has been a key stakeholder in the recruitment of regulatory affairs professionals across the European region for Global, European or International regulatory affairs roles. As … Continue reading

Posted in Job Hunting Advice, Orphan Drugs and Rare Diseases, Recruitment Market | Tagged , , , , , , , , , , , , , | Leave a comment

Liftstream Attending World Orphan Drug Congress in Geneva

Authored by Karl Simpson This week sees the World Orphan Drug Congress in Geneva, Switzerland. After a successful WODC event back in April in Washington, we’re looking forward to a very engaging conference with some of the industry’s most illustrious … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap